Abstract:Background: Type 1 diabetes (T1D) is a devastating autoimmune disease, and its rising prevalence in the United States and around the world presents a critical problem in public health. While some treatment options exist for patients already diagnosed, individuals considered at risk for developing T1D and who are still in the early stages of their disease pathogenesis without symptoms have no options for any preventive intervention. This is because of the uncertainty in determining their risk level and in predicting with high confidence who will progress, or not, to clinical diagnosis. Biomarkers that assess one's risk with high certainty could address this problem and will inform decisions on early intervention, especially in children where the burden of justifying treatment is high. Single omics approaches (e.g., genomics, proteomics, metabolomics, etc.) have been applied to identify T1D biomarkers based on specific disturbances in association with the disease. However, reliable early biomarkers of T1D have remained elusive to date. To overcome this, we previously showed that parallel multi-omics provides a more comprehensive picture of the disease-associated disturbances and facilitates the identification of candidate T1D biomarkers. Methods: This paper evaluated the use of machine learning (ML) using data augmentation and supervised ML methods for the purpose of improving the identification of salient patterns in the data and the ultimate extraction of novel biomarker candidates in integrated parallel multi-omics datasets from a limited number of samples. We also examined different stages of data integration (early, intermediate, and late) to assess at which stage supervised parametric models can learn under conditions of high dimensionality and variation in feature counts across different omics. In the late integration scheme, we employed a multi-view ensemble comprising individual parametric models trained over single omics to address the computational challenges posed by the high dimensionality and variation in feature counts across the different yet integrated multi-omics datasets. Results: the multi-view ensemble improves the prediction of case vs. control and finds the most success in flagging a larger consistent set of associated features when compared with chance models, which may eventually be used downstream in identifying a novel composite biomarker signature of T1D risk. Conclusions: the current work demonstrates the utility of supervised ML in exploring integrated parallel multi-omics data in the ongoing quest for early T1D biomarkers, reinforcing the hope for identifying novel composite biomarker signatures of T1D risk via ML and ultimately informing early treatment decisions in the face of the escalating global incidence of this debilitating disease.

Fast Bayesian Integrative Learning of Multiple Gene Regulatory Networks for Type 1 Diabetes

A Three-gene-based Type 1 Diabetes Diagnostic Signature

Supervised Parametric Learning in the Identification of Composite Biomarker Signatures of Type 1 Diabetes in Integrated Parallel Multi-Omics Datasets

Identification of Key Gene Pathways and Coexpression Networks of Islets in Human Type 2 Diabetes.

Bayesian joint modeling of multiple gene networks and diverse genomic data to identify target genes of a transcription factor

Joint Estimation and Inference for Data Integration Problems based on Multiple Multi-layered Gaussian Graphical Models

Simultaneous Modeling of Multiple Complications for Risk Profiling in Diabetes Care

High-Dimensional Joint Estimation of Multiple Directed Gaussian Graphical Models

Integrating Multiple Protein-Protein Interaction Networks to Prioritize Disease Genes: a Bayesian Regression Approach

Uncovering the gene regulatory network of type 2 diabetes through multi-omic data integration

AI-driven Integration of Multimodal Imaging Pixel Data and Genome-wide Genotype Data Enhances Precision Health for Type 2 Diabetes: Insights from a Large-scale Biobank Study

Large-scale dynamic gene regulatory network inference combining differential equation models with local dynamic Bayesian network analysis

Bayesian Inference of Networks Across Multiple Sample Groups and Data Types

A Bayesian Approach to Joint Estimation of Multiple Graphical Models

Exploring Biomarker Relationships in Both Type 1 and Type 2 Diabetes Mellitus Through a Bayesian Network Analysis Approach

In Silico Prediction of Potential Drug Combinations for Type 2 Diabetes Mellitus by an Integrated Network and Transcriptome Analysis

Evaluation of Bayesian Linear Regression Derived Gene Set Test Methods

A New Insight into Underlying Disease Mechanism Through Semi-Parametric Latent Differential Network Model

A New Dynamic Bayesian Network for Integrating Multiple Data in Estimating Gene Networks.

Joint estimation of multiple dependent Gaussian graphical models with applications to mouse genomics

Statistical Inference on High Dimensional Gaussian Graphical Regression Models